XML 154 R139.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION (Deferred and Restricted Stock) (Details)
$ / shares in Units, employees in Thousands, $ in Millions
6 Months Ended 12 Months Ended
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
yr
employees
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Outstanding, shares, beginning balance   0    
Outstanding, shares, ending balance     0  
Total Compensation Expense | $   $ 359 $ 261 $ 352
Stock-based compensation expense related tax benefit | $   $ 133 $ 97 $ 129
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Transfers Out, Grant Date Fair Value | $ / shares   $ 63.24    
Nonvested Performance Deferred Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Outstanding, shares, beginning balance   4,454,000    
Nonvested, weighted average grant date fair value per share, beginning of period | $ / shares   $ 55.85    
Granted, shares   1,960,000    
Weighted-average grant date fair value per share, granted | $ / shares   $ 80.71    
Canceled, shares   (131,000)    
Weighted average grant date fair value per share, canceled | $ / shares   $ 58.91    
Outstanding, shares, ending balance 232,000 232,000 4,454,000  
Nonvested, weighted average grant date fair value per share, end of period | $ / shares $ 71.16 $ 71.16 $ 55.85  
Performance Deferred Compensation [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Transfers Out   (6,051,000)    
Deferred Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized Compensation Cost | $ $ 165 $ 165    
Employee Service Share-based Compensation, Nonvested, Total Compensation Cost not yet recognized and period for recognition in years | yr   1.64    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested But Not Issued   20,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Outstanding, shares, beginning balance   6,382,000    
Nonvested, weighted average grant date fair value per share, beginning of period | $ / shares   $ 47.49    
Granted, shares   1,709,000    
Weighted-average grant date fair value per share, granted | $ / shares   $ 61.29 $ 46.25 $ 49.42
Vested, shares   (2,804,000)    
Weighted-average fair value per share of deferred stock granted vested | $ / shares   $ 47.60    
Canceled, shares   (112,000)    
Weighted average grant date fair value per share, canceled | $ / shares   $ 50.14    
Outstanding, shares, ending balance 13,346,000 13,346,000 6,382,000  
Nonvested, weighted average grant date fair value per share, end of period | $ / shares $ 50.71 $ 50.71 $ 47.49  
Total fair value of deferred stock vested and delivered | $   $ 179 $ 166 $ 162
Total fair value of deferred stock vested and delivered, related tax benefit | $   66 61 60
Total Compensation Expense | $   178 97 110
Stock-based compensation expense related tax benefit | $   $ 66 36 41
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested But Not Issued, Weighted Average Grant Date Fair Value | $ / shares   $ 35.99    
Deferred Compensation, Share-based Payments [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Transfers In   8,171,000    
Share-Based Compensation Arrangement y Share-Based Payment ward, Equity Instruments Other then Options, Transfers In, Grant Date Fair Value | $ / shares   $ 49.94    
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost | $   $ 25    
Share-Based Compensation Arrangement By Share-Based Payment Award, Plan Modification, Incremental Allocated Share-Based Compensation Expense | $ $ 20 $ 5    
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Number of Employees Affected | employees   5    
Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized Compensation Cost | $ $ 15 $ 15    
Employee Service Share-based Compensation, Nonvested, Total Compensation Cost not yet recognized and period for recognition in years | yr   1.66    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Total fair value of deferred stock vested and delivered | $   $ 202 103 37
Employee Service Share-based Compensation, Tax Benefit Realized from Vesting of Performance Deferred Stock Awards | $   75 38 14
Total Compensation Expense | $   106 125 172
Stock-based compensation expense related tax benefit | $   $ 39 $ 46 $ 63
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period   616,000 861,000 327,000
Employee Service Share-based Compensation, Cash Flow Effect, Cash Used to Settle Awards | $   $ 38 $ 40 $ 16
Non-Employee Directors' Stock Incentive Plan 2012 [Member] | Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Nonvested, weighted average grant date fair value per share, beginning of period | $ / shares   $ 50.55 $ 51.51  
Nonvested, weighted average grant date fair value per share, end of period | $ / shares $ 62.04 $ 62.04 $ 50.55 $ 51.51
Deferred Compensation Arrangement with Individual, Shares Issued   33,000 32,000 32,000
Maximum [Member] | Deferred Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vested Award but not issued as of period end and expected date of issuance   3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   3 years    
Maximum [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   3 years    
Minimum [Member] | Deferred Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vested Award but not issued as of period end and expected date of issuance   1 year    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   1 year    
Minimum [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   1 year    
September 1, 2017 - August 31, 2019 [Member] [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Granted, shares   232,000    
Weighted-average grant date fair value per share, granted | $ / shares   $ 71.16    
January 1, 2016 - December 31, 2018 [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Granted, shares   1,728,000    
Weighted-average grant date fair value per share, granted | $ / shares   $ 81.99    
January 1, 2015 - December 31, 2017 [Member] [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Granted, shares     2,283,000  
Weighted-average grant date fair value per share, granted | $ / shares     $ 52.68  
January 1, 2014 - December 31, 2016 [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Actual number of shares granted above target minimum range   0.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Granted, shares       2,258,000
Weighted-average grant date fair value per share, granted | $ / shares       $ 59.08
Actual number of shares granted above target maximum range   200.00%    
January 1, 2013 - December 31, 2015 [Member] | Performance Deferred Stock Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Actual number of shares granted above target minimum range   0.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Actual number of shares granted above target maximum range   200.00%